Cyanate as a hemolytic factor

Renal Failure

Volumn 22, Issue 6, 2000, Pages 809-814

  Mun, Kyo Cheol ^a   Kim, Hyun Chul ^a   Kwak, Chun Sik ^a  

^a Keimyung University School of Medicine   (South Korea)

Author keywords

Anemia; Carbamylation; Cyanate; End Stage Renal Failure, Hemolysis

Indexed keywords

CYANIC ACID; HEMOLYTIC AGENT; UREA;

ANEMIA; ARTICLE; DIALYSIS; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; KIDNEY FAILURE; PRIORITY JOURNAL; UREA BLOOD LEVEL;

ANEMIA, HEMOLYTIC; BLOOD UREA NITROGEN; CYANATES; ERYTHROCYTES; HEMOLYSIS; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 0033727763     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100101966     Document Type: Article

References (17)

1. Hematologic consequence of renal failure
2. End-stage kidneys are capable of increased erythropoietin production
3. Evidence that inhibition of erythropoiesis is important in the anemia of chronic renal failure
4. Superoxide anion generation, erythrocytes superoxide dismutase activity, and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients
5. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure
6. The intensity of hemodialysis and the response to Erythropoietin in patients with end-stage renal disease
7. Relationship between anemia and adequacy of continuous ambulatory peritoneal dialysis
8. The effect of hemodialysis and continuous peritoneal dialysis on renal anemia
9. Determination of cyanate, a study of its accumulation in aqueous solutions of urea
10. The pathophysiology of uremia
11. Hemoglobin carbamylation in uremia
12. Essential carbamoyl-amino acids formed in vivo in patients with end-stage renal disease managed by continuous ambulatory peritoneal dialysis: Isolation, identification, and quantitation
13. Carbamylation inhibits the ferroxidase activity of caeruloplasmin
14. Factors determining hemoglobin carbamylation in renal failure
15. Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients
16. Plasma cyanate concentrations in chronic renal failure
17. Carbamylation-induced alterations in low-density lipoprotein metabolism